Impella heart pumps boost Abiomed revenue

Daniel Allar | | Cardiovascular Business | Economics

Abiomed has reported second quarter revenue of $132.8 million, a 29 percent increase from the same period last year. Net income was reported at $24.5 million compared to $8.9 million for the prior year period.

Most of the growth is tied to worldwide revenue from the Impella heart pumps, which are used to provide circulatory support for heart failure patients and heart attack patients in cardiogenic shock. The Impella pumps generated $127.4 million in total revenue in the quarter, including a record $113.6 million in the U.S., where patient usage grew by 33 percent.

"This quarter, we set new records for supporting patients in the U.S. and Germany and we continue to observe improved clinical outcomes with our education and training initiatives," Michael R. Minogue, chairman, president and CEO of Abiomed, said in a statement. "I am proud of the team's ability to consistently adapt and execute as we transform the standard of care and build the field of heart recovery."

In a separate press release issued Oct. 26, the company announced its first patient in Japan had been treated with an Impella heart pump.

""
Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."